ALL >> Business >> View Article
Kosamattam Finance Limited Ncd Details

Kosamattam Finance Limited NCD Period Starts From Mar 19, 2020, To Apr 15, 2020:
Regardless, the Kerala-based Kosamattam Finance Limited has typified in 1987. So at that point, it came up as a non-store taking NBFC and functions as a gold advance supplier. In addition, the organization has a decent reach in the Union Territory of Puducherry, Maharashtra, Delhi, and Andhra Pradesh. It additionally has its reality in Karnataka, Telangana, Gujarat, Tamil Nadu, and Kerala.
While the organization comes as a RBI enlisted NBFC and furthermore has a Full-Fledged Money Changers (FFMC) permit. Notwithstanding, it likewise holds a testament of enrollment to fill in as a Depository Participant and Corporate Agent.
Essentially, the organization assembles itself to present another Non-Convertible Debentures Fund. The reserve appears to begin on March 19, 2020 and would stay shut by April 15, 2020.
NCD Details:
Bid Period March 19, 2020 – April 15, 2020
Security Name Kosamattam Finance Ltd.
Security Type Secured, Redeemable, Non-Convertible Debentures (Secured NCDs), and Unsecured ...
... Subordinated Non-Convertible Debentures (Unsecured NCDs)
Issue Size (Base) Rs 150.00 crores
Issue Size (Shelf) Rs 300.00 crores
Issue Price Rs 1000 for each NCD
Face value Rs 1000 each NCD
Minimum Lot Size 10 NCD
Market Lot 1 NCD
Posting At BSE
Credit rating IND BBB/Stable
Tenor 15 Mon/21 Mon/39 Mon/48 Mon/66 Mon/84 Months
Series Series I to Series VIII
Installment Frequency Monthly and Cumulative
Premise of Allotment First Come First Serve Basis
The organization has wanted to raise a base size of Rs 150 crores. So at that point, the financial specialists need to contribute at least 10 bonds. What's more, in products of 1 NCD bond. Likewise, the presumptive worth of the plan remains Rs 1000 for NCD bond. Additionally, it gives different loan costs and residencies of 15, 21, 39, 48, 66, and 84 months. Be that as it may, it comes accessible in 8 arrangement.
Kosamattam Finance Ltd. NCD Coupon Rates:
Arrangement Frequency Tenor (in Months) Coupon Rate Maturity Amount
I Cumulative 15 NA Rs 1,120
II Monthly 21 9.75% Rs 1,000
III Monthly 39 10% Rs 1,000
IV Cumulative 39 NA Rs 1,385
V Cumulative 48 NA Rs 1,500
VI Cumulative 66 NA Rs 1,750
VII Monthly 84 10.25% Rs 1,000
VIII Cumulative 84 NA Rs 2,000
Additionally, the NCD proposed to remain gave under "IND BBB" standpoint stable, by Indian Ratings and Research Private Limited. In addition, the sum faced Rs 35,000 lakhs dated September 30, 2019.
Disclaimer: This article gives data about the plan. It doesn't offer any guidance or suggestion. It would be ideal if you counsel your money related guide before contributing.
Add Comment
Business Articles
1. Stem-xpert At Web Summit Qatar 2025, Pursuing Innovative Solutions In Stem-as-a-serviceAuthor: stem-xpert
2. Deepseek’s Rapid Rise: Disrupting The Ai Market Amid Controversy
Author: Iconic success
3. Reimagining Customer Services With Microsoft Dynamics 365 Implementation
Author: Maria
4. Upcoming Developments In Ss Flanges: Possible Effects On Different Industries
Author: Neelam Forge India
5. Mg Hector 5 Seater Price In Chennai: A Detailed Review
Author: balaji
6. Mg Hector Ev Price In Chennai: A Comprehensive Overview
Author: balaji
7. Spring Marketing Trends: How Print And Video Can Refresh Your Brand
Author: Devin Herz
8. Auto Transport Services In South Carolina
Author: Secure Car Shipping
9. Authentication Of Australian Certificates In Canada: A Complete Guide
Author: anzilanx
10. Low Maintenance Plants For Home Landscaping
Author: Apunga Landscapes
11. The Ultimate Guide To Rocking Chairs – Comfort, Style, And Elegance
Author: tushar
12. Bioethanol Market Size Insights Forecast 2024-2030
Author: Nilam Jadhav
13. Touffy Fabric Upholstered Rocking Chair – The Perfect Blend Of Comfort And Elegance
Author: tushar
14. Maximizing Efficiency: Why Small Businesses Should Outsource Bookkeeping And Financial Services
Author: KMK Ventures Pvt Ltd
15. Big Patient Data And The Future Of Real World Evidence: Learnings From Biotechx 2024
Author: Industry Chronicle